Pfizer Inc. has announced a significant licensing agreement with China’s Sciwind Biosciences, focusing on its type 2 diabetes treatment known as ecnoglutide. The deal, valued at...
The week of November 2, 2023, saw notable movements among dividend-paying companies, particularly among the Dividend Champions, Contenders, and Challengers. These categories highlight companies renowned for...
